Viewing Study NCT00544700


Ignite Creation Date: 2025-12-26 @ 12:15 PM
Ignite Modification Date: 2026-02-25 @ 9:41 PM
Study NCT ID: NCT00544700
Status: TERMINATED
Last Update Posted: 2020-02-20
First Post: 2007-10-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bevacizumab in Treating Patients Who Have Undergone First-Line Therapy for Metastatic Colorectal Cancer
Sponsor: Swiss Cancer Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None stage IV colon cancer View
None stage IV rectal cancer View